ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME

This adverse event was reported 208 times

These drugs are most commonly taken by patients reporting ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME:

# Drug Count
0 TRETINOIN 78
1 ARSENIC TRIOXIDE 67
2 CYTARABINE 29
3 DEXAMETHASONE 23
4 DEXAMETHASONE 1.5 MG 23
5 METHOTREXATE 23
6 METHOTREXATE SODIUM 23
7 MITOXANTRONE 23
8 MITOXANTRONE HYDROCHLORIDE 23
9 ALLOPURINOL 13
See all common drugs associated with ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME

ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ARSENIC TRIOXIDE 67 0.0290
1 TRETINOIN 78 0.0095
2 ATRACURIUM BESYLATE 3 0.0042
3 MITOXANTRONE HYDROCHLORIDE 23 0.0037
4 CASPOFUNGIN ACETATE 5 0.0032
5 MEGNESIUM OXIDE 1 0.0024
6 ENASIDENIB MESYLATE 6 0.0018
7 IDARUBICIN HYDROCHLORIDE 2 0.0017
8 VANCOMYCIN HYDROCHLORIDE 11 0.0013
9 AMILORIDE HYDROCHLORIDE 1 0.0012
See all drugs enriched for association with ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME

ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Echinocandin Antifungal [EPC] 5 0.0006
1 Retinoid [EPC] 82 0.0003
2 Lipid-based Polyene Antifungal [EPC] 3 0.0002
3 Antifibrinolytic Agent [EPC] 2 0.0002
4 Glycopeptide Antibacterial [EPC] 11 0.0002
5 Nucleoside Metabolic Inhibitor [EPC] 34 0.0001
6 Penem Antibacterial [EPC] 4 0.0001
7 Azole Antifungal [EPC] 17 0.0001
8 Oxazolidinone Antibacterial [EPC] 3 0.0001
9 Polyene Antifungal [EPC] 4 0.0001
See all drug classes enriched for association with ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME